Showing results (2101-2110 of 2,741) with videos related to

Sort By:
Pageof 275
Critical Care Medicine|April 1, 1996
Low lipid concentrations in critical illness: implications for preventing and treating endotoxemiaB R Gordon, T S Parker, D M Levine, et al.
Infection and Immunity|December 1, 1987
Role of a 60-megadalton plasmid and Shiga-like toxins in the pathogenesis of infection caused by enterohemorrhagic Escherichia coli O157:H7 in gnotobiotic pigletsS Tzipori, H Karch, K I Wachsmuth, et al.
Annals of Internal Medicine|October 6, 1997
Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphomaE Zuckerman, T Zuckerman, A M Levine, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|January 1, 1987
Path model of multidimensional compliance with cancer therapyJ L Richardson, G Marks, C A Johnson, et al.
Chest|November 13, 2022
Hospital-Level Care at Home for Patients With Acute Respiratory Disease: A Descriptive AnalysisCarme Hernandez, Ann-Marcia C Tukpah, Henry M Mitchell, et al.
Cancer Research|October 1, 1992
Epidemiological and biological study of acquired immunodeficiency syndrome-related lymphoma in the County of Los Angeles: preliminary resultsA M Levine, D Shibata, J Sullivan-Halley, et al.
The Journal of Clinical Investigation|March 1, 1987
Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humansM M Levine, D Herrington, J R Murphy, et al.
AIDS (London, England)|April 20, 2004
Low incidence of invasive cervical cancer among HIV-infected US women in a prevention programL Stewart Massad, Eric C Seaberg, D Heather Watts, et al.
Pediatric Infectious Disease|January 1, 1986
Safety, infectivity, transmissibility and immunogenicity of rhesus rotavirus vaccine (MMU 18006) in infantsG A Losonsky, M B Rennels, A Z Kapikian, et al.
Cancer|February 1, 1994
Phase I clinical evaluation of a new murine monoclonal antibody (Mu-9) against colon-specific antigen-p for targeting gastrointestinal carcinomasR M Sharkey, D M Goldenberg, R Vagg, et al.
Pageof 275